The sperm protein fertilin (also known as PH-30) is a candidate for mediating the interactions between sperm and egg plasma membranes. Fertilin is a heterodimer. The b subunit, which has a region with homology to the family of integrin ligands known as disintegrins, has been hypothesized to be involved in the binding of sperm to the egg surface. 
INTRODUCTION
, complement component C3b associated with the equatorial segment of acrosome-reacted sperm (Anderson et al., 1993) , compleThe molecular basis of interactions between sperm and ment component C1q and its receptor (Fusi et al., 1991) , egg plasma membranes is poorly understood. Specific doextracellular matrix proteins (Fusi and Bronson, 1992 ; Fusi mains on the sperm membrane (equatorial segment and poset al., 1994; Hoshi et al., 1994) , and novel molecules identiterior head) and egg membrane (microvillar region) are infied by anti-sperm antibodies that inhibit sperm-egg bindvolved in this process (Yanagimachi, 1994) , and several caning and/or fusion (Cuasnicú et al., 1984; Saling et al., 1985 ; didate molecules on both gametes' surfaces have been Primakoff et al., 1987; Okabe et al., 1988 Okabe et al., , 1990 ; proposed to participate in the binding and/or fusion of the GarcıB a- Framis et al., 1994; Allen and Green, 1995) . Likegamete membranes. Sperm candidates include a galactosylwise, egg candidates include a trypsin-and chymotrypsintransferase on the equatorial segment (Lopez and Shur, 1987) , CD46 (also known as membrane cofactor protein; sensitive protein of M r Å 94,000 (Kellom et al., 1992) , the C1q receptor (Fusi et al., 1991) , integrins that recognize remains unclear. It has been hypothesized that fertilin b, the Arg-Gly-Asp (RGD) tripeptide sequence (Bronson and via its disintegrin domain, mediates sperm-egg membrane Fusi, 1990; Bronson et al., 1995) , the C3b receptor integrin binding, and that fertilin a, via its fusion peptide, mediates a M b 2 (Anderson et al., 1993) , the laminin receptor integrin sperm-egg fusion (Blobel et al., 1992; . Howa 6 b 1 (Almeida et al., 1995) , and antigens of antibodies to ever, to date, there has been no direct evidence to support egg surfaces (Jin et al., 1996) . this hypothesis. Indirect evidence for the role of fertilin b in The sperm antigen fertilin (formerly known as PH-30) is cell adhesion comes from the demonstration that synthetic one of the most promising candidates to mediate gamete peptides corresponding to the disintegrin domain inhibit interactions for the following reasons. First, it is localized sperm-egg membrane interactions ; Alto the posterior head of sperm, a region that is involved in meida et al., 1995; Evans et al., 1995b) . While some heterobinding to and fusion with the egg membrane (Primakoff et dimeric proteins are functional in the dimerized form (e.g., al., 1987) . Second, the monoclonal antibody PH-30, which integrins; Buck et al., 1986) , there are data which suggest recognizes fertilin, inhibits sperm-egg fusion (Primakoff et that the fertilin b subunit, in the absence of the a subunit, al., 1987) . Third, fertilin is a heterodimer that is proteolytiis functional Almeida et al., 1995;  Evans cally processed from a full-length precursor form to a maet al., 1995b) . Furthermore, since the fertilin b and a subture form at a time during epididymal transit that correunits have been hypothesized to have different roles in fersponds to the acquisition of fertilization competence (Blobel tilization (binding and fusion, respectively) , it is worthwhile et al ., 1990) . Finally, cDNA cloning and sequence analysis to examine each subunit individually. In the present study, reveals that the fertilin a subunit contains a region with we have expressed the extracellular domain of the predicted homology to viral fusion peptides, suggestive of a role for mature, proteolytically processed b subunit in bacteria as fertilin a in sperm-egg fusion. Moreover, the fertilin b suba fusion protein with maltose-binding protein (MBP); hereunit contains a domain with homology to a family of inteafter, this fusion protein will be referred to as recombinant grin ligands known as disintegrins, suggesting a cell adhefertilin b-EC. We demonstrate that recombinant fertilin bsive function for fertilin b (Blobel et al., 1992) .
EC binds to eggs with properties similar to those of sperm Disintegrins, originally identified in snake venom prowith respect to localization, inhibition of binding by synteins (Gould et al., 1990) , interact with integrins through a thetic peptides corresponding to the disintegrin domain, redomain containing tripeptide sequences that mimic the duced binding to chymotrypsin-treated eggs, and divalent Arg-Gly-Asp (RGD) tripeptide recognition sequence of cation dependence of binding. Moreover, recombinant fervarious integrin ligands. A new family of cellular disintetilin b-EC inhibits sperm binding to eggs. These data are grin-related molecules comprise the ADAM (A Disintegrin the first direct evidence that implicate fertilin b on sperm and Metalloprotease domain) or MDC (Metalloproteaseas a cell adhesion molecule involved in mediating the bindDisintegrin-Cysteine rich) family (Wolfsberg et al., 1995a) .
ing of sperm to the egg membrane. These proteins include the fertilins [identified in six species It has also been postulated that fertilin b, via its disinte- (Wolfsberg et al., 1993; Evans et al., 1995b; grin domain, interacts with an integrin or integrin-like mol-1995; Wolfsberg et al., 1995b; Hardy and Holland, 1996;  ecule on the plasma membrane of the egg (Blobel et al., Ramarao et al., 1996; Vidaeus et al., 1997) ], the meltrins 1992; . This is based on the finding that snake (Yagami-Hiromasa et al., 1995) , cyritestin (Barker et al., venom disintegrins interact with integrins, heterodimeric 1994; Heinlein et al., 1994; Wolfsberg et al., 1995b) , MDC9 membrane proteins of a and b subunits that mediate cell- (Weskamp et al., 1996) , metargidin (Krä tzschmar et al., matrix and cell-cell interactions (Gould et al., 1990; Haas 1996) , and the Drosophila Kuzbanian (Rooke et al., 1996). and Plow, 1994; Loftus et al., 1994) . In agreement with this All of these molecules have similar domain structures, inhypothesis, the a 6 b 1 integrin is implicated in mouse sperm cluding a signal sequence, a prodomain, a metalloprotease binding to mouse eggs (Almeida et al., 1995) , and a M b 2 and domain (although not all have a characteristic enzyme ac-RGD-binding integrins are implicated human sperm intertive site; Wolfsberg et al., 1995a) , a disintegrin domain, a actions with hamster eggs (Bronson and Fusi, 1990 ; Andercysteine-rich domain, an EGF-like repeat, a putative transson et al., 1993) . However, the only evidence of an interacmembrane domain, and a cytoplasmic tail (see Fig. 1A ). tion between fertilin b and an integrin is indirect. Synthetic Several of these proteins appear to be proteolytically propeptides corresponding to the disintegrin domain of fertilin cessed from precursor to mature forms  b have been reported to inhibit the binding of GoH3, an Linder et al., 1995; Yagami-Hiromasa et al., 1995) . The proanti-a 6 integrin monoclonal antibody, suggesting that the teolytic cleavage site in fertilin b lies between the metallopeptide and the GoH3 antibody bind to the same sites on protease and the disintegrin domains (Blobel et al., 1992) ; the egg surface (Almeida et al., 1995) . In this study we also thus, the mature form of fertilin b present on sperm conshow that the binding of recombinant fertilin b-EC to eggs tains in its extracellular domain only the disintegrin dois inhibited with an anti-b 1 integrin antibody, suggesting main, the cysteine-rich domain, and the EGF-like repeat that sperm fertilin b interacts with an egg b 1 integrin. How-(see Fig. 1A) .
ever, the function-blocking anti-a 6 antibody GoH3 had no While many members of the ADAM molecular family have been identified, the function(s) for several of them effect on the binding of recombinant fertilin b-EC.
Production of Recombinant Fertilin b-EC
this protocol was checked using three criteria: (1) detection of an electrophoretic shift by SDS-PAGE under reducing versus nonreThe region encoding the extracellular domain of mouse fertilin ducing conditions; (2) binding to ZP-free eggs, and (3) inhibiting b (nt 1165-2058, counting the A of the ATG start codon as nt 1) sperm binding in in vitro fertilization. For all series of experiments, was prepared by PCR amplification from mouse fertilin b plasmid at least two different batches of recombinant fertilin b-EC were DNA (Evans et al., 1995b ) with a 5 primer corresponding to nt used. 1165-1178 of Accession No. U16242 (Evans et al., 1995b) and engineered with a BamHI restriction site (CAGGATCCATGGCGG-TCTGTGG) and a 3 primer corresponding to nt 2045-2058 engiEgg Collection and Zona Pellucida Removal neered with a stop codon and a SalI restriction site (TTTTGTCGAEggs were obtained from superovulated CF-1 mice (Harlan, India-CTTACCGTGGAGACTTGG); amplification was performed in a napolis, IN) and cumulus cells were dispersed as previously de-PEC 2400 thermocycler (Perkin-Elmer, Norwalk, CT). For the exscribed (Evans et al., 1995b) . Unless otherwise indicated, the zona periments shown in Fig. 9 , recombinant fertilin b-EC lacking the pellucida (ZP) were removed by a very brief incubation (£15 sec) disintegrin domain was used; the DNA encoding this protein was in Acidic MEM-compatible buffer (Acidic MEMCO, 10 mM Hepes, prepared by PCR amplification using the 5 primer corresponding 1 mM NaH 2 PO 4 , 0.8 mM MgSO 4 , 5.4 mM KCl, 116.4 mM NaCl, to nt 1438-1454 of Accession No. U16242 and engineered with a final pH 1.5) and then allowed to recover for 60 min (Evans et al., BamHI restriction site (CAGGATCCTGTGACAATCGCAAGTG) 1995a); eggs treated in this way will be referred to as ''acid-treated.'' and the 3 primer shown above. The PCR products were then di-
The enzymatic-mechanical method of ZP removal described by gested with BamHI and SalI and cloned into pMAL-p2 (New En- Boldt and Wolf (1986) and Almeida et al. (1995) was also used; this gland Biolabs; Beverly, MA). The resulting plasmids encoding remethod is abbreviated ''CTM'' for chymotrypsin-mechanical. ZPcombinant fertilin b-EC (pMAL-b.10) (Fig. 1B ) and recombinant free eggs were then washed in Whitten's medium (Whitten, 1971) fertilin b-EC lacking the disintegrin domain (pMAL-bCE.2) were containing 15 mg/ml BSA and allowed to recover for at least 60 sequenced to verify that the insert was in frame and that the coding min in Whitten's medium containing 22 mM bicarbonate and 15 sequence was correct. Restriction enzyme digests, ligations, transmg/ml BSA in a gassed (5% CO 2 , 5% O 2 , 90% N 2 ) chamber. formations, and selections of transformants were performed according to standard protocols (Sambrook et al., 1989) .
Bacterial protein products and purified protein were analyzed by
Chymotrypsin Treatment of Eggs
12.5% SDS-PAGE (Laemmli, 1970) under reducing (sample buffer containing 20 mM DTT) or nonreducing conditions. Silver staining ZP-free eggs were treated with chymotrypsin essentially as preof SDS-PAGE gels was performed as described previously (Blum viously described (Boldt et al., 1988) . ZP-free eggs were washed et al., 1987) . For immunoblot analysis, proteins were electrophoretthrough six drops (100-200 ml each) of Whitten's medium conically transferred to an Immobilon P membrane (Millipore, Bedford, taining 0.01% polyvinyl alcohol (PVA; cold water soluble, 30,000-MA), probed with an anti-MBP antibody (1:10,000; New England 70,000 kDa; Sigma, St. Louis, MO), and then incubated in 1 mg/ml Biolabs) followed by a horseradish peroxidase (HRP)-conjugated a-chymotrypsin (type II from bovine pancreas, Sigma) in Whitten's goat anti-rabbit IgG secondary antibody (1:10,000; Jackson Immumedium containing PVA for 20 min at 37ЊC in a gassed (5% CO 2 , noresearch, West Grove, PA), and then detected with an enhanced 5% O 2 , 90% N 2 ) chamber. Following chymotrypsin treatment, eggs chemiluminescent (ECL) HRP substrate according to the manufacwere washed through six drops of Whitten's medium containing turer's instructions (Amersham, Arlington Heights, IL).
15 mg/ml BSA and allowed to recover for 45-60 min. pMAL-b.10-carrying DH5a Escherichia coli were determined to express a protein of the predicted size (M r Å 78,000, reducing conditions) that cross-reacted with anti-MBP antibodies on Western blots
Immunocytochemical Detection of Recombinant
in response to induction with isopropylthiogalactoside (IPTG;
Fertilin b-EC Binding to Eggs
Sigma, St. Louis, MO) but not in uninduced or untransformed bacteria (data not shown). For large-scale production of recombinant ZP-free eggs were incubated for 1 hr in varying concentrations of recombinant fertilin b-EC or MBP (0.5 mg/ml unless otherwise fertilin b-EC or MBP, a 1-liter culture of pMAL-b.10-or pMAL-p2-carrying DH5a E. coli was induced with 0.1 mM IPTG at 30ЊC for noted) in Whitten's medium containing 22 mM sodium bicarbonate and 15 mg/ml fatty acid-poor BSA in a gassed (5% CO 2 , 5% O 2 , 2 hr. Proteins from the bacterial periplasmic space were isolated by cold osmotic shock according to the manufacturer's instructions 90% N 2 ) chamber. Unless otherwise noted, Whitten's medium was supplemented so that the final concentrations of Ca 2/ and Mg 2/ (New England Biolabs). Recombinant fertilin b-EC (or MBP) was purified from the cold osmotic shock fluid by affinity chromatograwere 2.4 and 1.2 mM, respectively, and the final glucose concentration was 5.5 mM; the final concentration of BSA was 15 mg/ml. A phy on amylose resin (New England Biolabs). Protein-containing fractions were pooled and dialyzed against PBS, and then concen-CAQDEC peptide, corresponding to the disintegrin domain of mouse fertilin b, and a scrambled control peptide, CDEQAC, were trated to Ç1 mg/ml. On average, a 1-liter culture yielded 1-4 mg of recombinant fertilin b-EC. To prepare protein for egg-binding synthesized by Quality Controlled Biochemicals, and characterized for their ability to inhibit sperm binding in a concentration-depenstudies, recombinant fertilin b-EC was reduced by treating with 20 mM DTT for 30-60 min at room temperature. The sample was dent manner (Evans et al., 1995b) . Studies of recombinant fertilin b-EC binding in the presence of these peptides or divalent cations then dialyzed extensively against a Hepes-buffered Whitten's medium compatible dialysis buffer (WHITCO; 109.5 mM NaCl, 4.7 were performed using the culturing conditions described previously (Evans et al., 1995b) . mM KCl, 1.2 mM KH 2 PO 4 , 0.23 mM sodium pyruvate, 4.8 mM sodium lactate, 7 mM NaHCO 3 , 15 mM Hepes, 0.1 mg/ml gentamiFollowing incubation in recombinant fertilin b-EC, the eggs were washed through two 200-ml drops of medium and then fixed in search Diagnostics, Flanders, NJ), P4C10, anti-human b 1 (Gibcofreshly prepared 4.0% paraformaldehyde in PBS for 20-30 min. All BRL; Gaithersburg, MD), and several anti-human a v polyclonal ansteps were performed at room temperature in a humidified chamber tibodies (from Jeffrey W. Smith, Scripps Research Institute, and as described previously (Evans et al., 1995a) , using an anti-MBP from Gibco-BRL)] showed negligible cross-reactivity with epitopes antibody (New England Biolabs; diluted 1:300), followed by a goat on the surfaces of acid-treated and CTM-treated eggs and did not anti-rabbit IgG Texas red-conjugated secondary antibody (Jackson inhibit sperm binding or recombinant fertilin b-EC binding (data Immunoresearch) diluted 1:500 with 2 mg/ml DAPI (4,6-diamidinonot shown). 2-phenylindole; Sigma). For studies of in vitro maturation of GVAnti-integrin IgGs and control nonimmune rat and rabbit IgGs intact oocytes, FITC-conjugated phalloidin (final concentration 50 (Jackson Immunoresearch) were purified by chromatography on mg/ml; Sigma) was included with the secondary antibody. The eggs Protein G beads (Gibco-BRL). Antibodies were dialyzed against were mounted in VectaShield mounting medium (Vector Labs, Bur-WHITCO, and then concentrated to §5 mg/ml. For detection of lingame, CA), and were viewed by epifluorescence.
antibody binding, live ZP-free eggs were incubated in antibody (diluted to 0.5 mg/ml in Whitten's medium containing 15 mg/ml fatty acid-poor BSA) for 60 min at 37ЊC in a gassed (5% CO 2 , 5% O 2 ,
Luminometric Detection of Recombinant Fertilin
90% N 2 ) chamber. The eggs were then washed twice and fixed in freshly prepared 4.0% paraformaldehyde in PBS for 20-30 min at b-EC Binding to Eggs room temperature. Bound antibody was detected by both immunoFollowing incubation of eggs with recombinant fertilin b-EC, cytochemical and luminometric methods, using fluorophore-conjuthe eggs were washed as described above and fixed in freshly pregated goat-anti rat or rabbit IgG antibodies (diluted 1:500) or APpared 4% paraformaldehyde in PBS for 30 min. Fixed eggs were conjugated goat-anti rat or rabbit IgG antibodies (diluted 1:10,000), then washed twice in PBS and then blocked in alkaline phosphatase respectively. (AP)-blocking buffer (PBS containing 0.5% AP-free casein [I-block; For studies of the effects of anti-integrin antibodies on recombiTropix, Bedford, MA], 0.01% Tween 20, 0.02% sodium azide) for nant fertilin b-EC binding, ZP-free eggs were incubated with 0.5 either 60 min at room temperature or overnight at 4ЊC. The eggs mg/ml control IgG or anti-integrin IgG in Whitten's medium conwere then incubated in anti-MBP antibody diluted in AP-blocking taining 22 mM sodium bicarbonate, 15 mg/ml fatty acid-poor BSA buffer (1:300; New England Biolabs), washed three times in 0.05% for 60 min and then transferred to medium containing the same casein in PBS, incubated in AP-conjugated goat anti-rabbit IgG antibody (0.3 mg/ml) and 0.5 mg/ml recombinant fertilin b-EC. (1:10 4 dilution of 0.6 mg/ml stock; Tropix or Jackson ImmunoreFollowing a 60-min incubation the eggs were washed twice and search), and then washed nine times in 0.05% casein in PBS and assayed for recombinant fertilin b-EC binding using the luminomeonce in AP assay buffer (20 mM Tris-HCl, pH 9.5; 1 mM MgCl 2 ).
tric assay as described above. Binding levels of recombinant fertilin The egg-associated AP activity was then quantified in a luminomeb-EC in the presence of GoH3 or b 1 -B were expressed as a percenttric assay with a substrate that upon dephosphorylation decomage of its binding detected from eggs incubated in control nonimposes to an intermediate with the emission of photons. After this mune IgG. final wash, single eggs were transferred to 25 ml of AP assay buffer
In experiments in which eggs were incubated with both recombiin a 12 1 75-mm polystyrene tube (one egg per tube). One hundred nant fertilin b-EC (detected with an anti-rabbit IgG antibody that microliters of enhancer-substrate solution (AP assay buffer concross-reacted with the anti-MBP antibody) and GoH3 antibody (detaining 25 mM Sapphire II enhancer and 0.4 mM CSPD [disodium tected with an anti-rat IgG antibody), a species-specific goat anti-3-(4-methoxyspiro{1,2-dioxetane-3,2-(5-chloro)tricyclo rabbit IgG secondary antibody was used (Jackson Immunoresearch); [3.3.1.1 3, 7 ]decan}-4-yl)phenyl phosphate] substrate; Tropix) were control experiments verified that this antibody did not cross-react added to each tube that was incubated for 20 min at room temperawith the GoH3 antibody (data not shown). Experiments in which ture. The addition of substrate-enhancer solution was staggered the effects of rabbit anti-integrin antibodies (b 1 -B) were tested were by 15-sec intervals to ensure that each tube was assayed for photon complicated by the fact that the AP-conjugated goat anti-rabbit IgG emission 20 min following substrate addition. Photon emission secondary antibodies detects both the anti-integrin antibody and was measured by raw light units (RLUs) detected over a 10-sec the anti-MBP antibody used to detect bound recombinant fertilin duration (RLU/10 sec) in a Monolight 2010 luminometer (Analytib-EC. Unfortunately, we were unable to identify an anti-b 1 antical Luminescence Laboratory, San Diego, CA).
body that was not made in rabbit that cross-reacted with mouse egg b 1 and inhibited sperm or recombinant fertilin b-EC binding (data not shown); b 1 -B was the only antibody that we tested that
Anti-integrin Antibodies
possessed this activity. Therefore, levels of recombinant fertilin b-EC binding in the presence of b 1 -B were calculated by subtracting GoH3 (Immunotech, Westbrook, ME) is an anti-a 6 rat monothe luminometric signal detected from eggs incubated with b 1 -B clonal antibody with function-blocking activity (Sonnenberg et al., antibody from the signal detected from eggs incubated with b 1 -B 1988b, 1990); this antibody is specific for the a 6 subunit of the a 6 b 1 antibody plus recombinant fertilin b-EC. It was unlikely that the integrin heterodimer (Sonnenberg et al., 1988a) and immunoprecipsignal from eggs incubated with b 1 -B antibody and recombinant itates a 6 b 1 from mouse eggs (Tarone et al., 1993 ). An anti-rat b 1 fertilin b-EC was due to recombinant fertilin b-EC that had comrabbit polyclonal antibody made to wheat germ agglutinin-puripeted off the antibody, since we observed in separate experiments fiedb 1 subunit (Albelda et al., 1989) (provided by the laboratory of that recombinant fertilin b-EC dissociated more readily from egg Clayton Buck, Wistar Institute, and hereafter referred to as b 1 -B) surfaces than did the b 1 -B antibody. Specifically, levels of bound cross-reacts with several b 1 -containing integrin heterodimers (Sob 1 -B antibody did not decrease following a 60-min culture in the lowska et al., 1991) and immunoprecipitates b 1 (but not b 3 ) and absence of antibody, whereas the levels of bound recombinant ferseveral associated a subunits from mouse eggs (Evans et al., 1995a) .
tilin b-EC were reduced by 50% when eggs were cultured for 60 GoH3 and b 1 -B were found to bind to live ZP-free mouse eggs (present report). Other antibodies tested [9EG7, anti-mouse b 1 (Remin in the absence of protein (data not shown).
In Vitro Fertilization of ZP-Free Eggs
In vitro fertilization was performed and assayed as described previously (Evans et al., 1995b) . Prior to insemination, ZP-free eggs were incubated in 0.5 mg/ml MBP, recombinant fertilin b-EC, control IgG, or anti-integrin IgG for 60 min. Eggs were then incubated in drops (20 eggs per 10 ml drop) containing the same protein or antibody (at 0.3 mg/ml) and sperm (sperm concentrations used were 10,000, 25,000, and 100,000 sperm/ml, as indicated in the figure legends). As described previously, we observed only acrosome-reacted sperm bound to egg plasma membranes (Evans et al., 1995b) . Control experiments verified that sperm motility, sperm-egg binding, sperm-egg fusion, and development to the pronuclear stage were comparable in WHITCO and Whitten's medium (data not shown). Moreover, sperm motility, sperm-egg binding, sperm-egg fusion were comparable in inseminations in Whitten's medium, Whitten's medium containing WHITCO buffer, Whitten's medium containing 0.3 mg/ml MBP, and Whitten's medium containing 0.3 mg/ml control nonimmune IgG (data not shown).
RESULTS

Preparation of Recombinant Fertilin b-EC
Recombinant fertilin b-EC was purified from bacterial extracts using an amylose-affinity resin that binds to the MBP fusion partner. This fusion protein, however, formed large multimeric aggregates that migrated near the top of the gel under nonreducing conditions (Fig. 1C, lane 1) . This was likely due to the formation of intermolecular disulfide bonds in the periplasmic space of the bacteria during IPTGinduced expression; it should be noted that the extracellular region of fertilin b contains 34 cysteines residues (Evans et (Evans et al., 1995b) Furthermore, when the DTT was removed by dialysis, the (Fig. 1D, lanes 1 and 2) . these conditions (Fig. 1D, lanes 3 and 4) , since MBP does not contain cysteine residues (data not shown).
Qualitative and Quantitative Analysis of Binding
detected using immunocytochemistry. Recombinant ferof Recombinant Fertilin b-EC to Eggs tilin b-EC bound to the microvillar region of ZP-free eggs, the region to which sperm bind and fuse (Yanagimachi, The recombinant fertilin b-EC subjected to this reduction-oxidation protocol was able to bind to ZP-free eggs as 1994) ( Fig. 2A) . Binding to the amicrovillar region overlying were defined as 100% (Fig. 4) . Control proteins, such as MBP (Fig. 4A ) and rabbit IgG (data not shown), produced signals 100-250% that of signals from control eggs incubated in buffer. The binding of recombinant fertilin b-EC to eggs was also observed to be concentration dependent (Fig. 4B ). For the experiments described below, eggs were incubated in 0.5 mg/ml recombinant fertilin b-EC. the meiotic spindle, a region to which sperm do not bind, was never observed. Control eggs, incubated in either WHITCO buffer (data not shown) or with MBP ( Fig. 2B) , did not show any visible fluorescence on their surfaces. The observation that recombinant fertilin b-EC bound to the plasma membranes of eggs demonstrated that this protein has cell adhesive activity and suggested that the fertilin b subunit on sperm could mediate the binding of the gamete plasma membranes.
Inhibition of Binding of Recombinant
To complement the qualitative data from the immunofluorescence assay, we developed a luminometric assay to quantify the levels of recombinant fertilin b-EC binding. We first tested the detection of AP activity associated with goat-anti-rabbit IgG antibodies (GAR-AP); it should be noted that photon emission from samples of GAR-AP processed by this protocol could vary from day to day and with different sources of GAR-AP (data not shown). The rate of photon emission increased linearly through a range of GAR-AP concentrations [0-30 fg as shown (Fig. 3A) , and continuing up to 75 fg]. Moreover, photon emission gradually increased with time and plateaued 20 min following substrate addition to the samples containing various dilutions of GAR-AP (Fig. 3B) . We therefore read the samples after a 20-min incubation with substrate.
The binding of recombinant fertilin b-EC to a single egg that had been fixed and labeled with anti-MBP antibodies could be readily quantified with this assay (Fig. 4) . The photon emission signal from eggs and the signal-to-noise ratio of control eggs incubated in buffer alone; control signals guinea pig (TDE) fertilin b can inhibit fertilization in vitro Almeida et al., 1995; Evans et al., 1995b) . In our previous studies, 0.5 mM CAQDEC reduced sperm binding by 71%; this inhibition was concentration-dependent, as lower concentrations (0.25 mM and less) did not cause a statistically significant decrease in sperm binding (Evans et al., 1995b) . Similarly, 0.5 mM CAQDEC peptide reduced the binding of the recombinant fertilin b-EC to eggs (Fig. 5) . subsequent sperm-egg fusion (Boldt et al., 1988) suggests that an egg surface protein(s) mediate sperm-egg interactions. Accordingly, we examined if chymotrypsin treatment of ZP-free eggs reduced the ability of recombinant fertilin b-EC to bind to egg membranes. Eggs treated with 1 mg/ ml chymotrypsin for 20 min [conditions used by others (Boldt et al., 1988 (Boldt et al., , 1989 Kellom et al., 1992) ] showed a reduced ability to support recombinant fertilin b-EC binding (Fig. 6 ). Chymotrypsin-treated eggs bound Ç50% the amount of recombinant fertilin b-EC as compared to untreated eggs.
Effects of Divalent Cations on the Binding of Recombinant Fertilin b-EC to Eggs
Since it is well known that several cell adhesion molecules function in a divalent cation-dependent manner (Takeichi, 1990; Haas and Plow, 1994) , we previously characterized the divalent cation dependence of mouse sperm-egg membrane interactions (Evans et al., 1995b) . To extend our studies and to characterize recombinant fertilin b-EC's activity as a cell adhesion molecule, we examined the divalent cation dependence of the interaction of recombinant fertilin b-EC with egg plasma membranes. The luminometric assay Fig. 10 , the following control levels of sperm binding were eggs incubated in recombinant fertilin a-EC is defined as 100%).
observed: 1.25 { 0.27 sperm/acid-treated egg following inseminations using 10,000 sperm/ml; 2.93 { 0.35 sperm/acid-treated egg and 1.28 { 0.37 sperm/CTM-treated egg following inseminations using 25,000 sperm/ml; and 5.71 { 1.24 sperm/acid-treated egg and (39% of the binding observed in Whitten's; Fig. 7 ). This 3.58 { 0.45 sperm/CTM-treated egg following inseminations using suggested that trace amounts of divalent cations in the diva-100,000 sperm/ml. lent cation-deficient medium still supported some binding.
All three individual divalent cations tested (2.0 mM Ca ) supported the binding of recombinant fertilin b-EC to eggs at levels similar to that observed to eggs in Whitten's medium (Fig. 7) . These results were similar to our previous observation that sperm-egg binding is supported by the presence of Ca 2/ , Mg 2/ , or Mn 2/ as the only divalent cation in the medium (Evans et al., 1995b) .
Inhibition of Sperm Binding to Eggs during in Vitro Fertilization by Recombinant Fertilin b-EC
Sperm-egg binding is inhibited by synthetic peptides that contain the tripeptide QDE corresponding to the disintegrin ). Accordingly, we tested the ability of recombinant and binding of recombinant fertilin b-EC was determined using the fertilin b-EC to inhibit sperm-egg binding (Fig. 8) . Recomluminometric assay. Whitten's medium contains 2.4 mM Ca 2/ and binant fertilin b-EC (0.5 mg/ml, i.e., 6.4 mM) was used be- sperm binding (Almeida et al., 1995) used an IVF system very different from ours. Specifically, Almeida et al. (1995) performed their IVF experiments using very high sperm concentrations (0.5-1 1 10 6 /ml) and CTM-treated eggs, whereas we routinely use 10,000-25,000 sperm/ml and acid-treated eggs. Therefore, to mimic both our previous conditions (Evans et al., 1995b) and those of Almeida et al. (1995) , we performed experiments using two different ZP removal methods (acid treatment and CTM treatment) and three different sperm concentrations to study the effect of recombinant fertilin b-EC on sperm binding. In our IVF system, we generally used 10,000 or 25,000 sperm/ml when inseminating ZP-free eggs since this protocol generally results in one to three sperm bound per egg. We chose these sperm concentrations because in IVF of ZP-intact eggs, we have observed that usually one to three sperm are found in sperm (e.g., see Table 1 in Evans et al., 1995b) . For the domain at 0.5 mg/ml) and then inseminated with either 25,000 or 100,000 sperm/ml. The data are summarized from four (25,000 present studies, in addition to our standard method of using sperm/ml) or five (100,000 sperm/ml) individual experiments and 10,000-25,000 sperm/ml, we also used 100,000 sperm/ml tion, as concentrations ú200,000 sperm/ml usually proOpen bars, recombinant fertilin b-EC, which includes the disinteduced a significant number (ú20%) of polyspermic eggs in grin domain; closed bars, recombinant fertilin b-EC lacking the our IVF system (data not shown). disintegrin domain. In the experiments presented here, the followIn all experiments using these various conditions, sperm ing levels of sperm binding were observed for MBP-treated controls: 1.75 { 0.20 sperm/egg following inseminations using 25,000 binding to recombinant fertilin b-EC-treated eggs was resperm/ml, and 7.37 { 0.37 sperm/egg following inseminations usduced as compared to binding to control eggs, ranging 8-ing 100,000 sperm/ml. 60% of control levels and averaging 35% (Fig. 8) . Recombinant fertilin b-EC did not appear to inhibit sperm-egg fusion directly (examined further in Evans et al., 1997) . We observed that sperm that were able to bind to eggs were Effects of Anti-integrin Antibodies on Sperm also able to fuse with the egg's plasma membrane (data not
Binding to ZP-Free Eggs
shown). This same observation has been made with QDE peptides (Almeida et al., 1995; Evans et al., 1995b) , echiAn egg integrin has been hypothesized to serve as a bindstatin (Bronson et al., 1995) , and anti-a 6 antibodies (Almeida ing site for fertilin b on sperm (Blobel et al., 1992; , where sperm binding is reduced, but bound 1993). In the experiments reported by Almeida et al. (1995) , sperm can still fuse with peptide-, protein-, or antibodyan anti-b 1 polyclonal antibody partially inhibited spermtreated eggs.
egg binding, and an anti-a 6 function-blocking monoclonal We also examined the effects on sperm binding of a form antibody GoH3 almost completely blocked sperm-egg of recombinant fertilin b-EC that lacks the disintegrin dobinding. Since these results implicated a 6 b 1 in sperm bindmain; this protein binds to the microvillar region of eggs ing to eggs, and because fertilin b has a domain with homol-(as determined by immunocytochemistry) with a similar ogy to an integrin ligand, we examined whether this particuconcentration dependence (as determined by the luminomelar egg integrin has a role in the binding of recombinant tric assay) as does recombinant fertilin b-EC (data not fertilin b-EC to eggs. shown). Eggs incubated and then inseminated in the presPrior to these studies, however, we tested the effects of ence of recombinant fertilin b-EC lacking the disintegrin anti-integrin antibodies on sperm-egg interactions in our domain bound more sperm than did eggs incubated and then IVF system, since, as noted above, our IVF system differed inseminated in the presence of recombinant fertilin b-EC from that used by Almeida et al. (1995) in two important which includes the disintegrin domain (Fig. 9) . This obseraspects, namely, ZP removal and sperm concentration. We vation suggests that the disintegrin domain either includes tested the ability of different anti-integrin antibodies to inamino acids that are recognized by an egg binding site(s) or hibit sperm-egg binding by inseminating both acid-treated contributes sequence information required for the proper and CTM-treated eggs in vitro in different sperm concentrations in the presence of the antibodies. An anti-b 1 polyfolding of domain(s) involved in egg interactions.
clonal antibody moderately inhibited sperm binding to both acid-treated and CTM-treated eggs (averages of 69 and 58% of sperm binding to eggs in control IgG, respectively) (Fig.  10A) . The function-blocking anti-a 6 antibody GoH3 did not inhibit sperm binding to acid-treated eggs (average of 102% of controls) (Fig. 10B) . However, the GoH3 antibody did inhibit sperm binding to CTM-treated eggs (average 37% of controls; Fig. 10B) ; generally, 1-2 sperm were bound to CTM-treated eggs incubated in GoH3 antibody, in agreement with Almeida et al. (1995) . It should be noted that when the GoH3 antibody and recombinant fertilin b-EC were tested in parallel for their abilities to inhibit sperm binding to acid-treated eggs, recombinant fertilin b-EC had an inhibitory effect but the GoH3 antibody did not (data not shown). The antibodies also did not inhibit sperm-egg fusion (data not shown), in agreement with the findings of Almeida et al. (1995) .
Effects of Different ZP Removal Methods on the Ability of ZP-Free Eggs to Bind Anti-integrin Antibodies, Sperm, and Recombinant Fertilin b-EC Almeida et al. (1995) and we observed that GoH3 inhibited sperm binding to CTM-treated eggs, whereas we observed that GoH3 had no effect on sperm binding to acid-treated eggs (Fig.  10B) . To ascertain if the difference in the method used to prepare ZP-free eggs accounted for the difference in the ability of GoH3 antibody to inhibit sperm binding, we compared the ability of anti-integrin antibodies to bind to acid-treated and CTM-treated eggs. Using both immunocytochemistry (data not shown) and the luminometric assay (Fig. 11A) , we ob- (Fig. 11A) , suggesting that this antibody, an anti-a 6 integrin antibody, on sperm binding. ZP-free functional epitope of the a 6 integrin is modified by the acid eggs were prepared by acid treatment or by chymotrypsin-mechanical treatment (as indicated at the top of each panel). The experitreatment such that the epitope cannot be recognized by the ments were conducted using the antibodies at 0.5 mg/ml and the GoH3 antibody. In contrast, the anti-b 1 polyclonal antibody following sperm concentrations: 10,000 sperm/ml (A, Experiments (b 1 -B) bound very well to both CTM-treated eggs and acid-1 and 6; B, Experiments 1 and 2); 25,000 sperm/ml (A, Experiments treated eggs (1847% and 1242% of IgG-treated control eggs, 2, 3, and 7; B, Experiments 3, 4, and 8) ; and 100,000 sperm/ml (A, respectively) (Fig. 11B) . Experiments 4, 5, 8, and 9; B, Experiments 5, 6, 7, 9, and 10). Open In contrast to the finding that the GoH3 antibody bound eggs than to CTM-treated eggs (Fig. 12) . It should also be in which the decreased sperm binding observed in the appropriate noted that we observed that recombinant fertilin b-EC disanti-integrin antibody was statistically significant (P õ 0.05, t test) as compared to control IgG samples.
sociated from egg surfaces more readily than did the GoH3 inhibition of the binding of sperm fertilin b, we tested the ability of anti-integrin antibodies to inhibit the binding of recombinant fertilin b-EC to eggs. GoH3-treated eggs bound virtually equal amounts of recombinant fertilin b-EC as did control IgG-treated eggs, suggesting that GoH3 had no inhibitory effect on acid-treated eggs (96% of control; Fig.  13 ). This was expected since acid-treated eggs bound relatively little of the GoH3 antibody as compared to CTMtreated eggs (Fig. 11A) . However, GoH3 antibody also had very little inhibitory effect on the binding of recombinant fertilin b-EC to CTM-treated eggs; GoH3-treated eggs bound very similar amounts of recombinant fertilin b-EC as did control IgG-treated eggs (86% of control; Fig. 13 ). Wolfsberg et al., 1995a) have been either fixed immediately or washed and incubated for 60 min in the absence of protein or antibody. We found that eggs incubated with the GoH3 or b 1 -B antibodies had equal amounts of antibody bound to them when compared to antibody-treated eggs that were fixed immediately (data not shown). In contrast, washed eggs had approximately 50% the amount of bound recombinant fertilin b-EC when compared to recombinant fertilin b-EC-treated eggs that were fixed immediately (data not shown). Identical results were obtained with both acid-treated and CTM-treated eggs, with the exception that more recombinant fertilin b-EC and less GoH3 antibody bound to acid-treated eggs than to CTMtreated eggs (as shown in Figs. 11 and 12 ).
To summarize, the observation of the relatively low levels of GoH3 epitope on acid-treated eggs explained our inability to inhibit sperm binding to acid-treated eggs with the GoH3 antibody (Figs. 10B and 11A ). However, this result functional GoH3 a 6 epitope implicated in sperm-egg bindincubated in 0.5 mg/ml of the indicated anti-integrin antibody ing (Almeida et al., 1995 ) and yet these acid-treated eggs (GoH3 or b 1 -B) for 60 min and then incubated in 0.5 mg/ml of bound more sperm and greater amounts of recombinant ferrecombinant fertilin b-EC and 0.3 mg/ml of the indicated antibody tilin b-EC than did CTM-treated eggs (Fig. 12) . anti-a 6 integrin antibodies on sperm binding was due to an Copyright ᭧ 1997 by Academic Press. All rights of reproduction in any form reserved.
proposed to represent a new class of cell adhesion molecules et al., 1988) . Finally, also in agreement with previous studies of mouse sperm binding (Evans et al., 1995b) , we observe based on their deduced amino acid sequence (Blobel et al., 1992; Wolfsberg et al., 1995a) . The evidence for this, howthat the binding of recombinant fertilin b-EC to eggs is dependent on divalent cations (Fig. 7) . Binding levels in diever, is indirect and is based solely on the disruption of cell-cell interactions with peptides corresponding to the valent cation-deficient medium containing 0.5 mM EGTA are 39% of the binding levels observed in control medium, disintegrin domain of fertilin b Almeida et al., 1995; Evans et al., 1995b , and Mn 2/ (2.0 mM) are each capable of supporting similar levels of binding of recombinant fertilin b-EC, extracellular domain of the fertilin b subunit (recombinant fertilin b-EC) binds to the microvillar region of ZP-free eggs, suggesting that one divalent cation can substitute for another and that none of these divalent cations inhibits bindthe region to which sperm bind. It is possible that fertilin b dimerized with fertilin a may have additional or different ing. This agrees with our findings on the divalent cation dependence of sperm-egg binding (Evans et al., 1995b) . The activities. It should also be noted that the native fertilin a/ b heterodimer on sperm, fertilin a/b heterodimer purified divalent cation dependence of fertilin b-EC binding to eggs implies that the conformation of the fertilin b ligand on from sperm, or recombinant fertilin subunit(s) expressed in a eukaryotic system may fold differently from recombinant sperm and/or the binding partner(s) on eggs requires divalent cations. This is not surprising as several families of fertilin b-EC that is expressed in bacteria and renatured as described, and thus these proteins may have additional or cell adhesion molecules, including cadherins and some integrins, recognize their ligands in a divalent cation-dependent different properties. Nevertheless, this binding ability of recombinant fertilin b-EC suggests that the fertilin b submanner (Takeichi et al., 1990; Haas and Plow, 1994; Loftus et al., 1994) . unit has adhesive activity by itself, i.e., fertilin b does not need to be expressed as a heterodimer with the fertilin a Several groups have suggested that egg integrins mediate sperm-egg membrane interactions (Bronson and Fusi, 1990 ; subunit or any other ADAM family member to bind to eggs. Moreover, these results also suggest that fertilin b does not Anderson et al., 1993; Almeida et al., 1995; Bronson et al., 1995) . The finding that an a 6 function-blocking antibody, require either the putative transmembrane or cytoplasmic domains for its adhesive activity. Finally, since bacterially GoH3, inhibits sperm binding, coupled with the ability of an a 6 -deficient cell line transfected with an a 6 expression expressed recombinant fertilin b-EC is not glycosylated, glycosylation is not required for the recombinant protein plasmid to bind sperm, suggests that an a 6 egg integrin participates in sperm-egg interactions (Almeida et al., 1995) . to have adhesive activity.
The binding properties of recombinant fertilin b-EC are Fertilin b has been proposed to be a ligand for a 6 b 1 based on the observations that fertilin b contains a disintegrin similar to those of sperm in three ways: (a) reduced binding in the presence of CAQDEC peptides; (b) reduced binding domain (Blobel et al., 1992; Evans et al., 1995b; Wolfsberg et al., 1995b) , and that peptides corresponding to the disinteto chymotrypsin-treated eggs; and (c) the divalent cation dependence of binding. These points are elaborated as folgrin domain have been reported to reduce the binding of GoH3 antibody to egg surfaces (Almeida et al., 1995) . Our lows. CAQDEC peptides corresponding to the disintegrin domain inhibit recombinant fertilin b-EC binding to eggs studies with anti-integrin antibodies support the hypothesis that a b 1 integrin(s) on eggs is involved in sperm and recom- (Fig. 5 ) in a manner similar to the way they inhibit sperm binding to eggs (Evans et al., 1995b) , suggesting that the binant fertilin b-EC binding. In agreement with Almeida et al. (1995) , we find that an anti-b 1 antibody reduces sperm binding of recombinant fertilin b-EC to eggs is mediated, at least in part, by the QDE-containing disintegrin domain binding (Fig. 10A ). More importantly, we present the first evidence that an egg b 1 integrin may serve as a binding of fertilin b. It has been suggested that, within the disintegrin loop CRLAQDECDVTEYC, the actual active tripeptide site for fertilin b on sperm, since this anti-b 1 antibody also reduces the binding of recombinant fertilin b-EC to eggs is ECD, two amino acids toward the carboxy terminus from the QDE sequence, based on sequence conservation be- (Fig. 13) . The a integrin subunit(s) that is partnered with the b 1 tween fertilin b in five different species (Perry et al., 1995; Hardy and Holland, 1996) . It should be noted, however, that subunit and that participates in the binding of recombinant fertilin b-EC has not been identified; this identification will synthetic peptides that inhibited sperm binding in two different studies did not include the D of the ECD sequence require additional studies that are beyond the scope of the present paper. The functional a 6 epitope identified by the Evans et al., 1995b) . Nevertheless, it is possible that this region and/or other regions mediates the monoclonal antibody GoH3 has been proposed to be involved in sperm-egg binding and it has been reported that binding of fertilin b to its cognate binding site(s) on eggs.
Recombinant fertilin b-EC appears to interact with a chypeptides corresponding to the disintegrin domain of fertilin b to inhibit GoH3 antibody binding to CTM-treated eggs motrypsin-sensitive site on eggs, since treatment of eggs with this protease results in eggs with a reduced ability to (Almeida et al., 1995) . Nevertheless, the sperm ligand for egg a 6 b 1 has not been directly identified, and moreover, two bind recombinant fertilin b-EC (Fig. 6) . Such treatment also results in eggs with a reduced ability to bind sperm (Boldt lines of evidence presented here suggest that a 6 does not
